Sympathetic nervous system neuroplasticity

Hypertension

Volumn 47, Issue 2, 2006, Pages 143-144

  Esler, Murray ^a   Kaye, David ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN; NORADRENALIN;

ADRENERGIC SYSTEM; ADULTHOOD; CELL SURVIVAL; EDITORIAL; EMBRYO DEVELOPMENT; HEART FAILURE; HUMAN; NERVE CELL PLASTICITY; NONHUMAN; NORADRENALIN UPTAKE; PRIORITY JOURNAL; STELLATE GANGLION; VERTEBRATE;

ANIMALS; HEART FAILURE, CONGESTIVE; HUMANS; INJECTIONS; MYOCARDIUM; NERVE GROWTH FACTOR; NEURONAL PLASTICITY; NOREPINEPHRINE; STELLATE GANGLION; SYMPATHETIC NERVOUS SYSTEM;

EID: 31944447449     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000200024.12746.f3     Document Type: Editorial

References (21)

1. Hasking G, Esler M, Jennings G, Burton D, Johns J, Korner P. Norepinephrine spillover to plasma in congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
2. Himura Y, Felten SY, Kashiki M, Lewandowski TJ, Delehanty JM, Liang CS. Cardiac noradrenergic nerve terminal abnormality in dogs with experimental congestive heart failure. Circulation. 1993;88:1299-1309.
3. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667-1676.
4. Kaye DM, Vaddadi G, Grushkin SL, Du X-J, Esler MD. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res. 2000;86:e80-e84.
5. Kreusser MM, Haass M, Buss SJ, Hardt SE, Gerber SH, Kinscherf R, Katus HA, Backs J. Injection of nerve growth factor into stellate ganglia improves norepinephrine re-uptake into failing hearts. Hypertension 2006;47:209-215.
6. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987;237:1154-1162.
7. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736.
8. Wilson RF, Christensen BV, Olivari MT, Simon A, White CW, Laxson DD. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. Circulation. 1991;83:1210-1220.
9. Kaye D, Esler M, Kingwell B, Jennings G, McPherson G, Esmore D. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation. 1993; 88:1101-1109.
10. Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M. Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med. 2001;345:731-738.
11. Minami E, Laflamme MA, Saffitz JE, Murry CE. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation. 2005;112:2951-2958.
12. Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand. 2003; 177:275-284.
13. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, MacMahon SB, Shelton DL, Lenvinson AD. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell. 1994;76:1001-1011.
14. Kiriazis H, Du X-J, Feng X, Hotchkin E, Marshall T, Finch S, Goa X-M, Lambert G, Choate JK, Kaye DM. Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation. Am J Physiol Heart Circ Physiol. 2005;289:H1359-H1365.
15. Cao J-M, Chen LS, KenKnight BH, Ohara T, Lee M-H, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC, Chen P-S. Nerve sprouting and sudden death. Circ Res. 2000;86:816-821.
16. Qin F, Vulapalli RS, Stevens SY, Liang C-S. Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF. Am J Physiol Heart Circ Physiol. 2002;282:H363-H371.
17. Wakade AR, Wakade TD, Poosch M, Bannon MJ. Noradrenaline transport and transporter mRNA of rat chromaffin cells are controlled by dexamethasone and nerve growth factor. J Physiol (Lond). 1996;494:67-75.
18. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension. 1998;31:64-67.
19. Head RJ. Hypernoradrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels. 1991;28:173-178.
20. Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, and Kopin IJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med. 1997;336:696-702.
21. Packer M, Bristow MR, Colucci WS, Fowler MB, Gilbert EM, and Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.